Tüm alıştırma soruları

8270 soru

Soru 2161Soru →

Review the clinical vignettes describing five different patients presenting with hematologic abnormalities. Based on the provided clinical presentations and laboratory profiles, which peripheral blood smear finding best matches each patient?

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 32-year-old woman with systemic lupus erythematosus presents with progressive fatigue and scleral icterus. Laboratory evaluation reveals a hemoglobin of 8.1 g/dL, a reticulocyte count of 7%, and an elevated indirect bilirubin level.
A 68-year-old man who underwent a mechanical aortic valve replacement three years ago presents with fatigue and dark urine. Laboratory evaluation reveals a hemoglobin of 9.4 g/dL, a normal platelet count, and normal coagulation studies.
A 72-year-old man presents with a 6-month history of progressive fatigue. Laboratory evaluation reveals a hemoglobin of 8.5 g/dL and an MCV of 112 fL. Serum vitamin B12, red blood cell folate, and thyroid-stimulating hormone levels are within normal limits.
A 64-year-old man presents with early satiety and a dragging sensation in his left abdomen. Physical examination is notable for massive splenomegaly. Laboratory evaluation reveals a hemoglobin of 9.2 g/dL and a white blood cell count of 12,000/mm³. A bone marrow aspiration yields a "dry tap".
A 45-year-old man with a history of severe alcohol use disorder presents with fatigue, an ataxic gait, and lower extremity paresthesias. Laboratory evaluation reveals a hemoglobin of 9.0 g/dL and an MCV of 116 fL.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Patient 1 (SLE, hemolysis) matches with Spherocytes and polychromasia. Patient 2 (Mechanical valve, hemolysis) matches with Schistocytes and helmet cells. Patient 3 (Elderly, macrocytosis, normal vitamins) matches with Hyposegmented, hypogranular neutrophils. Patient 4 (Splenomegaly, dry tap) matches with Teardrop cells (dacrocytes) and nucleated red blood cells. Patient 5 (Alcoholism, neuropathy, macrocytosis) matches with Hypersegmented neutrophils and macro-ovalocytes.
The correct matches pair distinct clinical syndromes with their pathognomonic peripheral blood smear findings. Extravascular hemolysis in autoimmune disease produces spherocytes. Intravascular mechanical shear stress produces schistocytes. Bone marrow dysplasia (MDS) leads to hyposegmented neutrophils. Marrow fibrosis produces teardrop cells. Finally, impaired DNA synthesis from vitamin B12 deficiency leads to hypersegmented neutrophils.

Adım Adım Çözüm

1
Analyze the etiology of anemia in the 32-year-old woman with SLE.
The patient has warm autoimmune hemolytic anemia, matching with spherocytes and polychromasia.
SLE predisposes to IgG-mediated hemolysis, causing splenic macrophages to bite off portions of the RBC membrane, forming spherocytes without central pallor.
2
Identify the cause of hemolysis in the 68-year-old man with a mechanical valve.
The patient has macroangiopathic hemolytic anemia, matching with schistocytes.
Mechanical shearing of RBCs by the artificial valve leads to intravascular hemolysis and the formation of schistocytes. Normal platelets differentiate this from microangiopathic processes like TTP.
3
Evaluate the 72-year-old man with macrocytic anemia and normal vitamin levels.
The patient most likely has a myelodysplastic syndrome (MDS), matching with hyposegmented, hypogranular neutrophils.
MDS frequently presents in elderly patients with macrocytic anemia. The smear classically shows dysplastic features such as the pseudo-Pelger-Huet anomaly.
4
Assess the 64-year-old man with massive splenomegaly and a 'dry tap'.
The clinical picture indicates primary myelofibrosis, matching with teardrop cells.
Bone marrow fibrosis results in a dry tap and extramedullary hematopoiesis in the spleen. This process forces RBCs through fibrotic marrow, producing teardrop cells.
5
Diagnose the 45-year-old man with macrocytosis and neurologic deficits.
The patient has a megaloblastic anemia due to vitamin B12 deficiency, matching with hypersegmented neutrophils.
Neurologic symptoms paired with an elevated MCV point to B12 deficiency, which impairs DNA synthesis and produces hypersegmented neutrophils (≥5 lobes) and macro-ovalocytes.

Anahtar Kavram

Correlation of distinct anemia etiologies and bone marrow disorders with their characteristic peripheral blood smear morphologies.
Tahmini Süre:1m 30s
Soru 2162Soru →

A 68-year-old man is brought to the emergency department by his daughter due to worsening confusion, profound fatigue, and severe lower back pain over the past two weeks. He has a history of hypertension. Temperature is 37.1°C (98.8°F), blood pressure is 110/70 mmHg, pulse is 112/min, and respiratory rate is 16/min. Physical examination reveals dry mucous membranes and point tenderness over the L3 and L4 vertebrae. Neurologic examination shows no focal deficits, but the patient is lethargic and oriented only to name.

Laboratory studies show:
- Hemoglobin: 8.9 g/dL
- Platelet count: 140,000/mm³
- Leukocyte count: 4,500/mm³
- Serum calcium: 13.8 mg/dL
- Serum creatinine: 2.8 mg/dL (baseline 0.9 mg/dL)
- Blood urea nitrogen: 56 mg/dL
- Total protein: 10.2 g/dL
- Albumin: 3.1 g/dL

Arrange the following management and diagnostic steps in the most appropriate chronological sequence for this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence prioritizes acute stabilization of severe hypercalcemia with intravenous fluids, followed by initial non-invasive laboratory diagnosis (protein electrophoresis), non-invasive skeletal staging (whole-body CT), definitive invasive diagnosis (bone marrow biopsy), and finally, targeted induction chemotherapy.
The correct chronological sequence reflects both emergency medicine principles and standard oncologic workflows. The patient has critical hypercalcemia and acute kidney injury necessitating immediate isotonic saline administration. Once stabilized, the diagnostic workup proceeds from non-invasive (serum protein electrophoresis and whole-body low-dose CT to establish CRAB criteria) to invasive (bone marrow biopsy to establish clonality and cytogenetics). Targeted chemotherapy is only appropriate after a complete diagnostic and prognostic evaluation is finished.

Adım Adım Çözüm

1
Recognize the oncologic emergency (severe hypercalcemia and acute kidney injury) in the context of suspected malignancy.
Identify the need for immediate metabolic and hemodynamic stabilization.
A serum calcium level of 13.8 mg/dL with altered mental status is life-threatening and takes absolute clinical precedence over further diagnostic workup.
2
Identify the most likely underlying diagnosis based on the clinical picture (anemia, hypercalcemia, kidney injury, bone pain, and elevated protein gap).
Suspect Multiple Myeloma as the primary etiology.
This classic 'CRAB' presentation requires a highly specific, stepwise diagnostic algorithm starting with the least invasive tests.
3
Determine the correct sequence of the multiple myeloma diagnostic workup.
Prioritize non-invasive blood tests, then imaging, followed by invasive procedures.
Serum protein electrophoresis confirms the monoclonal protein. CT scans identify bone lesions. Bone marrow biopsy provides definitive cellular and cytogenetic confirmation.
4
Determine the precise timing for initiating definitive systemic therapy.
Place induction chemotherapy as the final step in the sequence.
Chemotherapy should only be started after accurate cytogenetic risk stratification from the bone marrow biopsy is available to guide regimen selection.

Anahtar Kavram

The management of suspected multiple myeloma presenting with an oncologic emergency requires immediate metabolic stabilization (IV fluids for hypercalcemia) prior to a stepwise diagnostic approach: non-invasive laboratory confirmation, imaging for skeletal involvement, invasive bone marrow biopsy, and finally systemic chemotherapy.
Tahmini Süre:2m 30s
Soru 2163Soru →

A 5555-year-old woman with a history of diffuse large B-cell lymphoma presents to the emergency department with chills and a fever. She received her last cycle of R-CHOP chemotherapy 88 days ago. Her temperature is 38.6∘C38.6^\circ\text{C} (101.5∘F101.5^\circ\text{F}), blood pressure is 110/70 mmHg110/70\text{ mmHg}, and heart rate is 105/min105/\text{min}. Physical examination reveals a central venous port in the right upper chest with no surrounding erythema. Her absolute neutrophil count is pending but is suspected to be severely low.

Arrange the following steps in the correct chronological order for the optimal initial and subsequent management of this patient's condition.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence of management for suspected febrile neutropenia is: 1) Rapid clinical assessment, 2) Obtaining blood cultures, 3) Administering empiric broad-spectrum antibiotics, and 4) Adjusting the antibiotic regimen based on culture results.
The management of febrile neutropenia follows a strict, time-sensitive sequence. First, the patient must be clinically assessed for hemodynamic stability. Immediately following this, blood cultures (both peripheral and from any central lines) must be obtained. Crucially, these cultures must be drawn before the administration of broad-spectrum antibiotics to prevent sterilizing the sample. Empiric antipseudomonal antibiotics are then started immediately (ideally within 60 minutes of presentation). Finally, the antibiotic regimen is tailored once specific culture and sensitivity data return in the following days.

Adım Adım Çözüm

1
Assess the patient clinically for hemodynamic stability.
Airway, breathing, circulation, and vital signs are rapidly evaluated.
Immediate life threats must be identified and stabilized before any targeted diagnostic or therapeutic interventions begin.
2
Draw blood cultures from central and peripheral sites.
Blood is collected for microbiological analysis.
Pathogen identification is critical. Drawing cultures before giving antibiotics maximizes the chance of growing the organism and determining sensitivities.
3
Initiate empiric intravenous antibiotics.
An antipseudomonal beta-lactam (e.g., cefepime or piperacillin-tazobactam) is administered.
Neutropenic patients lack the immune response required to fight bacterial infections, making rapid empiric coverage life-saving.
4
Re-evaluate and tailor antimicrobial therapy.
Antibiotics are adjusted once culture results and susceptibilities are finalized.
Tailoring therapy provides targeted treatment, reduces toxicity, and minimizes the development of antimicrobial resistance.

Anahtar Kavram

Sequential management protocol for febrile neutropenia
Soru 2164Soru →

A 9-month-old female infant is brought to the clinic by her parents for a routine well-child evaluation. She was born at 28 weeks of gestation via spontaneous vaginal delivery following preterm labor. Her neonatal intensive care unit stay was prolonged, but she was eventually discharged home in stable condition without oxygen dependence. The parents are highly concerned that she is falling behind her peers in their neighborhood playgroup. They report she cannot crawl, pull herself to a standing position, or pick up small snacks with her thumb and index finger. She has no other significant past medical history. On physical examination, the infant appears well-nourished and interactive. She is able to sit unsupported momentarily but primarily relies on placing her hands in front of her for balance when leaning forward. She successfully transfers a small toy from one hand to the other. When offered a small piece of cereal, she uses a raking motion with all her fingers to grasp it. She babbles single syllables but does not use words meaningfully. When the physician holds the infant in vertical suspension and abruptly lowers her headfirst toward the examination table, she does not extend her arms to break the fall. Which of the following is the most accurate assessment of this patient's developmental status?

Cevabı ve açıklamayı göster

Cevap: Age-appropriate development when adjusted for premature birth

Cevap

The infant's development is completely age-appropriate when adjusted for her premature birth.
This infant was born at 28 weeks of gestation, which is 12 weeks (approximately 3 months) premature. For prematurely born infants, developmental milestones must be adjusted for gestational age until the child reaches 2 years of chronological age. Therefore, this 9-month-old infant's corrected age is 6 months. Her current skills—tripod sitting, transferring objects from hand to hand, utilizing a raking grasp, and babbling single syllables—are all standard, normal developmental milestones for a 6-month-old child. Furthermore, the parachute reflex (extending the arms to break a fall when lowered headfirst) typically emerges at 8 to 9 months of age and remains for life. Its absence at a corrected age of 6 months is completely normal and expected, strongly ruling out upper motor neuron pathology such as cerebral palsy at this stage.

Adım Adım Çözüm

1
Calculate the infant's corrected gestational age.
9 months chronological age - 3 months premature (born at 28 weeks) = 6 months corrected age.
Developmental milestones must be adjusted for prematurity until the child reaches 24 months of chronological age.
2
Evaluate the infant's gross and fine motor skills against the corrected age.
Tripod sitting (relying on hands for balance), hand-to-hand toy transfer, and a raking grasp are perfectly appropriate for a 6-month-old.
The parents' expectations of crawling, pulling to stand, and a mature pincer grasp reflect 9-month milestones, which are not yet expected for this prematurely born patient.
3
Analyze the absent parachute reflex noted on the physical examination.
The parachute reflex typically emerges at 8 to 9 months of age; its absence at a corrected age of 6 months is a normal physiologic finding.
This confirms the absence of pathological upper motor neuron signs in the context of appropriate corrected-age development.

Anahtar Kavram

Developmental milestone adjustment for prematurity and normal reflex maturation.
Soru 2165Soru →

Targeted biologic and synthetic disease-modifying antirheumatic drugs (DMARDs) have revolutionized the management of rheumatologic conditions, but they carry risks for unique and severe adverse effects. Match each clinical vignette describing a therapy-related complication with the specific medication class most likely responsible.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 52-year-old man with refractory rheumatoid arthritis develops new-onset exertional dyspnea, orthopnea, and pitting lower extremity edema three months after starting a biologic agent; an echocardiogram reveals a newly reduced left ventricular ejection fraction of 35%.
A 61-year-old woman with severe rheumatoid arthritis on a biologic agent develops progressive cognitive decline, hemiparesis, and ataxia over several weeks; brain MRI demonstrates non-enhancing, asymmetric white matter lesions without mass effect.
A 58-year-old man of Mediterranean descent with refractory tophaceous gout receives a new intravenous urate-lowering therapy and presents three days later with acute jaundice, dark urine, and a peripheral smear showing bite cells and Heinz bodies.
A 64-year-old woman with rheumatoid arthritis develops a severe, intensely painful vesicular eruption in a dermatomal distribution across her right thorax shortly after adding a new oral targeted synthetic DMARD to her regimen.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct mappings are:
1. The patient with new-onset heart failure matches with TNF-alpha inhibitors.
2. The patient with Progressive Multifocal Leukoencephalopathy (PML) matches with Anti-CD20 monoclonal antibodies.
3. The patient with G6PD-associated hemolytic anemia matches with Recombinant uricase.
4. The patient with Herpes zoster reactivation matches with Janus kinase (JAK) inhibitors.
Each advanced rheumatologic medication class operates via distinct pathophysiologic mechanisms that lead to highly specific toxicities. TNF-alpha inhibitors depress myocardial function. Anti-CD20 agents deplete B-cells allowing opportunistic JC virus reactivation. Recombinant uricase generates oxidative stress, unmasking G6PD deficiency. JAK inhibitors impair antiviral signaling, predisposing specifically to VZV reactivation.

Adım Adım Çözüm

1
Analyze the first vignette describing new-onset systolic heart failure following biologic initiation.
Identify TNF-alpha inhibitors as the responsible class.
TNF-alpha inhibition can paradoxically depress myocardial function and worsen or induce heart failure in susceptible individuals.
2
Evaluate the second vignette detailing subacute cognitive decline and focal neurologic deficits with non-enhancing white matter lesions.
Identify this as Progressive Multifocal Leukoencephalopathy (PML) linked to Anti-CD20 monoclonal antibodies.
Rituximab profoundly depletes B-cells, impairing the immune surveillance required to keep the JC virus latent, leading to central nervous system demyelination.
3
Assess the third vignette describing oxidative hemolysis (bite cells, Heinz bodies) after gout treatment.
Identify Recombinant uricase (pegloticase) as the trigger.
Pegloticase generates hydrogen peroxide. In individuals with G6PD deficiency (common in Mediterranean descent), this overwhelms antioxidant defenses, causing hemolysis.
4
Examine the fourth vignette depicting dermatomal varicella-zoster virus reactivation.
Identify Janus kinase (JAK) inhibitors as the cause.
JAK-STAT pathway inhibition strongly suppresses interferon-mediated antiviral responses, making Herpes zoster a hallmark toxicity of this drug class.

Anahtar Kavram

Severe and unique adverse effect profiles of targeted DMARDs and biologic therapies in rheumatology.
Tahmini Süre:2m 0s
Soru 2166Soru →

A 38-year-old woman is brought to the emergency department by her husband due to a 2-day history of progressive, ascending muscle weakness and difficulty breathing. She also reports palpitations. She has a 5-year history of severe dry eyes, a persistent sensation of "cotton mouth," and recurrent bilateral parotid gland swelling. Her only daily medication is artificial tears.

Physical examination reveals a respiratory rate of 28/min, heart rate of 115/min, and blood pressure of 110/70 mmHg. She is using accessory muscles of respiration. Neurologic examination shows 2/5 motor strength in her proximal lower and upper extremities, and globally diminished deep tendon reflexes.

Laboratory studies show:
Sodium: 140 mEq/L
Potassium: 1.8 mEq/L
Chloride: 118 mEq/L
Bicarbonate: 10 mEq/L

Arterial blood gas on room air:
pH: 7.22
PaCO2PaCO_2: 38 mmHg
PaO2PaO_2: 85 mmHg

Endocrine studies obtained due to her profound weakness show a TSH of 0.2 μU/mL\mu U/mL (Normal: 0.4-4.0) and Free T4 of 0.6 ng/dL (Normal: 0.8-1.8).

Urinalysis shows a pH of 6.5 and 15 WBC/hpf. A urine culture obtained at an urgent care clinic two days ago is now resulting, showing >100,000 CFU/mL of *Escherichia coli* that is sensitive to nitrofurantoin, cephalexin, and trimethoprim-sulfamethoxazole.

Which of the following is the most accurate interpretation of this patient's current condition and the most appropriate initial management step?

Cevabı ve açıklamayı göster

Cevap: Non-anion gap metabolic acidosis with superimposed respiratory acidosis; immediately initiate intravenous potassium chloride.

Cevap

The most accurate interpretation is a non-anion gap metabolic acidosis with a superimposed respiratory acidosis; the immediate required management is intravenous potassium chloride.
The correct answer correctly identifies that the patient has a mixed acid-base disorder (non-anion gap metabolic acidosis from Type 1 RTA + superimposed respiratory acidosis from hypokalemic diaphragmatic paralysis). In this critical state, intravenous potassium must be the first intervention. Correcting the acidemia with bicarbonate without first correcting the potassium will drive residual extracellular potassium into cells, precipitating a lethal arrhythmia.

Adım Adım Çözüm

1
Diagnose the underlying condition based on clinical presentation.
The patient has a history of dry eyes, dry mouth, and parotid swelling, which is classic for primary Sjögren syndrome.
Recognizing the autoimmune etiology provides context for the subsequent renal complications.
2
Analyze the basic metabolic panel and calculate the anion gap.
Anion Gap = 140−(118+10)=12140 - (118 + 10) = 12. This indicates a non-anion gap metabolic acidosis (NAGMA).
NAGMA in the setting of Sjögren syndrome, accompanied by severe hypokalemia and basic urine (pH > 5.5), is highly indicative of Type 1 (distal) Renal Tubular Acidosis (RTA).
3
Evaluate the respiratory compensation using Winter's formula.
Expected PaCO2=(1.5×10)+8=23±2PaCO_2 = (1.5 \times 10) + 8 = 23 \pm 2 mmHg. The measured PaCO2PaCO_2 is 38 mmHg, which is significantly higher than expected.
This discrepancy confirms a superimposed primary respiratory acidosis caused by hypoventilation.
4
Correlate the physical exam findings with the laboratory data to determine the cause of respiratory failure.
The profound hypokalemia (1.8 mEq/L) is causing ascending muscle paralysis, which now involves the diaphragm, leading to respiratory failure and the superimposed respiratory acidosis.
Hypokalemia alters the resting membrane potential of muscle cells, leading to profound weakness and diminished reflexes.
5
Determine the appropriate sequencing of pharmacotherapy.
Intravenous potassium chloride must be administered immediately.
Administering sodium bicarbonate to correct the acidosis before replacing potassium will cause a transcellular shift of potassium into cells, worsening the hypokalemia and potentially precipitating fatal cardiac arrhythmias.

Anahtar Kavram

Extra-articular manifestations of Sjögren syndrome include Type 1 (distal) RTA, which can cause severe hypokalemia and ascending paralysis. When correcting the resulting metabolic acidosis, potassium must be repleted prior to or alongside bicarbonate to prevent fatal intracellular potassium shifts.
Soru 2167Soru →

For each pediatric patient presented below, select the most appropriate routine preventive care intervention or immunization milestone recommended for their specific age according to standard pediatric guidelines.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Newborn infant in the nursery prior to hospital discharge
12-month-old toddler presenting for a routine well-child visit
18-month-old toddler presenting for a routine well-child visit
11-year-old adolescent presenting for a routine well-adolescent visit

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Newborns receive the Hepatitis B vaccine; 12-month-olds receive their first MMR and Varicella vaccines; 18-month-olds undergo routine autism screening; and 11-year-olds receive Tdap, MenACWY, and HPV vaccines.
The Centers for Disease Control and Prevention (CDC) and the American Academy of Pediatrics (AAP) establish a standardized schedule for childhood immunizations and preventive screenings. Birth involves the Hepatitis B vaccine. The 12-month visit is a major milestone for initiating live vaccines (MMR, Varicella). The 18-month visit includes targeted, formal autism screening. The 11-year visit transitions the patient to adolescent care with Tdap, MenACWY, and HPV vaccines.

Adım Adım Çözüm

1
Identify the standard preventive care intervention for a newborn infant.
The Hepatitis B vaccine is the hallmark routine immunization given at birth.
This establishes early immunity and prevents perinatal transmission of the virus.
2
Determine the critical interventions scheduled for the 12-month visit.
Live vaccines (MMR and Varicella) are initiated at 12 months.
Circulating maternal antibodies wane by 12 months, allowing the child's immune system to mount an effective response to live vaccines.
3
Recall the specific developmental screening required at 18 months of age.
Autism-specific screening is routinely performed at 18 and 24 months.
Early detection of autism spectrum disorder significantly improves long-term developmental outcomes through early intervention.
4
Identify the adolescent vaccine bundle typically administered at 11 to 12 years of age.
The Tdap booster, MenACWY, and HPV vaccines are administered.
These vaccines provide protection against pertussis, meningococcal meningitis, and HPV-related cancers during adolescence and adulthood.

Anahtar Kavram

Routine pediatric preventive care schedule, including indicated immunizations and targeted developmental screening milestones.
Soru 2168Soru →

Review the following clinical vignettes describing patients who are experiencing complications related to underlying malignancies. Match each patient's clinical presentation with the primary pathophysiologic mechanism responsible for their symptoms.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 68-year-old man with a newly discovered right hilar mass presents with proximal muscle weakness that transiently improves with repetitive movement, accompanied by dry mouth and absent deep tendon reflexes.
A 55-year-old woman with a history of treated breast cancer presents with subacute, rapidly progressive truncal ataxia, dysarthria, and multidirectional nystagmus. Brain magnetic resonance imaging reveals no intracranial metastases.
A 42-year-old man with bulky mediastinal lymphadenopathy, fever, and drenching night sweats develops anasarca. Laboratory studies show a serum albumin of 2.1 g/dL and a 24-hour urine protein of 5.2 g.
A 72-year-old man with an apical lung mass and a 50-pack-year smoking history presents with confusion, polyuria, and abdominal pain. Laboratory evaluation reveals a serum calcium of 14.2 mg/dL and an intact parathyroid hormone of 5 pg/mL.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Lambert-Eaton syndrome (hilar mass) matches with antibodies against presynaptic calcium channels. Paraneoplastic cerebellar degeneration (breast cancer) matches with immune destruction of Purkinje cells. Minimal change disease (mediastinal mass/Hodgkin lymphoma) matches with cytokine-mediated foot process effacement. Humoral hypercalcemia of malignancy (apical lung mass) matches with ectopic PTHrP secretion.
Each clinical vignette provides a classic presentation of a distinct paraneoplastic syndrome. The first is Lambert-Eaton myasthenic syndrome (LEMS) caused by anti-calcium channel antibodies. The second is paraneoplastic cerebellar degeneration caused by anti-Purkinje cell antibodies. The third is minimal change disease secondary to Hodgkin lymphoma, caused by cytokine-induced podocyte injury. The fourth is humoral hypercalcemia of malignancy caused by tumor secretion of PTHrP.

Adım Adım Çözüm

1
Analyze the first vignette to identify the syndrome and its underlying mechanism.
The combination of a central lung mass, proximal muscle weakness improving with use, and autonomic dysfunction indicates Lambert-Eaton myasthenic syndrome, caused by antibodies against presynaptic voltage-gated calcium channels.
Recognizing the classic triad of LEMS and its association with small cell lung cancer is required to identify the molecular mechanism.
2
Analyze the second vignette to identify the syndrome and its underlying mechanism.
Subacute ataxia in a breast cancer patient with a negative brain MRI points to paraneoplastic cerebellar degeneration, which is driven by onconeural antibodies (such as anti-Yo) destroying Purkinje cells.
Ruling out brain metastasis is crucial; the subacute cerebellar presentation in breast cancer is a classic paraneoplastic neurological syndrome.
3
Analyze the third vignette to identify the syndrome and its underlying mechanism.
Mediastinal lymphadenopathy with B symptoms implies Hodgkin lymphoma, and new-onset nephrotic syndrome in this context is almost always minimal change disease caused by T-cell cytokine release effacing podocyte foot processes.
Linking specific malignancies with their associated paraneoplastic glomerulopathies allows identification of the correct pathophysiology.
4
Analyze the fourth vignette to identify the syndrome and its underlying mechanism.
Severe hypercalcemia with suppressed PTH in a smoker with a lung mass indicates squamous cell carcinoma secreting PTH-related peptide (PTHrP), which activates PTH1 receptors.
Differentiating PTH-mediated hypercalcemia from PTHrP-mediated hypercalcemia is essential in oncologic emergencies.

Anahtar Kavram

Paraneoplastic syndromes possess specific pathophysiologic mechanisms that must be correlated with their associated underlying malignancies and varied clinical presentations.
Soru 2169Soru →

During a routine wellness check, a 68-year-old retired carpenter describes gradually worsening right knee discomfort over the past two years. He notes the pain is most pronounced after an afternoon of gardening and improves when he sits in his recliner. He denies any systemic symptoms such as fever, fatigue, or unintended weight loss. Morning joint stiffness is minimal, rarely exceeding 15 minutes. Physical assessment of the right knee demonstrates palpable crepitus during active range of motion and prominent bony hypertrophy, but lacks joint effusion, significant warmth, or overlying erythema. A recent complete blood count and inflammatory marker panel were within normal limits. Which of the following pathophysiologic processes best explains this patient's current clinical presentation?

Cevabı ve açıklamayı göster

Cevap: Progressive degradation of articular cartilage and subchondral bone sclerosis

Cevap

Progressive degradation of articular cartilage and subchondral bone sclerosis
The clinical presentation of chronic, activity-related joint pain that improves with rest, brief morning stiffness lasting less than 30 minutes, and physical exam findings of crepitus and bony hypertrophy without warmth or erythema is the classic hallmark of osteoarthritis. Osteoarthritis is fundamentally a non-inflammatory, degenerative disorder characterized by the progressive loss of articular cartilage, leading to joint space narrowing, subchondral bone sclerosis, and the formation of osteophytes (bony hypertrophy).

Adım Adım Çözüm

1
Analyze the patient's demographic and symptom timeline.
The patient is an older adult with a chronic (two-year) history of gradually worsening knee pain.
Establishing the chronicity rules out acute processes like septic arthritis or acute crystal-induced arthropathy flares.
2
Evaluate the pain characteristics and morning stiffness.
Pain worsens with activity and improves with rest. Morning stiffness lasts less than 15 minutes.
This 'mechanical' pain pattern strongly points to a non-inflammatory degenerative process rather than an autoimmune systemic condition.
3
Interpret the physical exam and laboratory findings.
Exam shows crepitus and bony hypertrophy without warmth or erythema; inflammatory markers are normal.
These findings confirm a non-inflammatory arthropathy (osteoarthritis) and rule out rheumatoid arthritis, which presents with soft tissue swelling, warmth, and elevated inflammatory markers.
4
Correlate the diagnosis with the underlying pathophysiology.
Osteoarthritis is characterized by cartilage degradation and subchondral bone changes.
The correct option must describe the mechanism of osteoarthritis.

Anahtar Kavram

Pathophysiology and clinical diagnosis of osteoarthritis versus inflammatory arthritides
Soru 2170Soru →

A 52-year-old man is evaluated in the clinic for resistant hypertension. Despite adherence to a regimen of amlodipine, lisinopril, and chlorthalidone at maximum tolerated doses, his blood pressure remains poorly controlled at 168/102 mm Hg. He reports occasional muscle weakness but is otherwise asymptomatic. Laboratory studies reveal a serum potassium level of 3.1 mEq/L and a serum sodium level of 144 mEq/L. The physician suspects a secondary cause for his resistant hypertension. Arrange the following diagnostic steps in the most appropriate chronological order to definitively evaluate and subtype this patient's condition.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: 1) Discontinue interfering medications, 2) Measure the PAC/PRA ratio, 3) Perform a confirmatory suppression test, 4) Obtain an adrenal CT scan, 5) Perform bilateral adrenal venous sampling.
The evaluation of primary hyperaldosteronism must follow a strict algorithmic approach to prevent diagnostic errors and avoid unnecessary surgeries. First, interfering medications (especially ACE inhibitors, ARBs, and diuretics) must be discontinued because they alter renin and aldosterone levels, potentially causing false-negative screening results. Second, the initial screening is performed using the PAC/PRA ratio. Third, if the screen is positive, autonomous secretion must be confirmed with a suppression test (such as saline loading), as screening alone has a high false-positive rate. Fourth, once confirmed biochemically, an adrenal CT scan is obtained to identify macroscopic pathology and delineate venous anatomy. Finally, because non-functioning adrenal incidentalomas are highly prevalent, bilateral adrenal venous sampling is performed to definitively prove lateralization of aldosterone excess before committing the patient to a unilateral adrenalectomy.

Adım Adım Çözüm

1
Recognize the clinical presentation of suspected primary hyperaldosteronism.
Identify the need for a targeted, step-wise diagnostic workup.
Resistant hypertension combined with unprovoked or diuretic-induced hypokalemia is a classic presentation for mineralocorticoid excess.
2
Prepare the patient for biochemical screening by adjusting medications.
Transition from ACE inhibitors and diuretics to permissive agents like calcium channel blockers or alpha-blockers.
Diuretics and ACE inhibitors stimulate renin production, which can falsely lower the PAC/PRA ratio and lead to a false-negative screening result.
3
Perform the initial biochemical screening.
Measure the PAC/PRA ratio.
This is the most sensitive initial screening tool. A ratio >20 with a PAC >15 ng/dL suggests the diagnosis.
4
Confirm the diagnosis of autonomous aldosterone secretion.
Perform a suppression test, such as an intravenous saline infusion.
Screening tests have a high false-positive rate. Failure of aldosterone to suppress after a sodium load confirms autonomous production.
5
Classify the disease subtype using anatomical imaging.
Obtain a high-resolution adrenal CT scan.
Imaging helps identify macroscopic pathology, rules out large adrenal carcinomas, and maps the venous anatomy for subsequent invasive testing.
6
Differentiate unilateral adenoma from bilateral hyperplasia functionally.
Perform bilateral adrenal venous sampling (AVS).
Because adrenal incidentalomas are common in older adults, a CT scan alone cannot prove that a visible nodule is the source of excess aldosterone. AVS definitively identifies lateralization before committing the patient to a unilateral adrenalectomy.

Anahtar Kavram

The evaluation of primary hyperaldosteronism follows a strict sequence: Medication adjustment → Biochemical screening (PAC/PRA) → Biochemical confirmation (Suppression test) → Anatomical subtyping (CT scan) → Functional lateralization (Adrenal venous sampling).
Soru 2171Soru →

A 74-year-old male patient with known metastatic prostate carcinoma is evaluated in the emergency department for severe mid-thoracic back pain that has been escalating over the past week. During the last 24 hours, he has noted profound weakness in both of his legs and an inability to void urine. Vital signs are within normal limits. Neurologic evaluation demonstrates a motor strength of 2/52/5 in bilateral lower extremities, hyperactive patellar reflexes, positive Babinski signs bilaterally, and diminished pain sensation below the umbilicus.

Arrange the following steps in the most appropriate chronological order for the optimal management of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence for managing suspected malignant epidural spinal cord compression is to first administer intravenous dexamethasone, followed by an MRI of the entire spine, then consultation with surgical/radiation specialists, and finally the initiation of targeted definitive treatment.
Malignant epidural spinal cord compression typically presents with progressively worsening back pain followed by neurologic deficits, such as motor weakness, a distinct sensory level, and bowel or bladder dysfunction. The immediate, life-saving priority is administering high-dose intravenous dexamethasone to reduce inflammatory edema and prevent irreversible ischemia of the spinal cord. Only after steroids are given should the patient undergo an urgent MRI of the entire spine to confirm the diagnosis and map the anatomical extent of the disease. Once the MRI clarifies the extent of involvement, consultation with neurosurgery and radiation oncology is obtained. These specialists use the imaging to determine the most appropriate definitive therapy (e.g., surgical decompression versus primary radiation therapy), which is then initiated as the final step.

Adım Adım Çözüm

1
Identify the oncologic emergency based on clinical presentation
The patient exhibits classic signs of malignant epidural spinal cord compression (ESCC).
A history of metastatic cancer, rapidly worsening back pain, and distinct upper motor neuron signs in the legs (hyperreflexia, weakness, sensory level, urinary retention) strongly indicate ESCC.
2
Determine the immediate first step in management
Administer high-dose intravenous dexamethasone empirically.
Corticosteroids must be given immediately upon clinical suspicion to decrease vasogenic edema and prevent permanent, irreversible ischemic damage to the spinal cord.
3
Select the appropriate confirmatory diagnostic test
Perform an urgent MRI of the entire spine.
MRI is the most sensitive and specific test to confirm the presence, severity, and anatomical extent of the spinal cord compression.
4
Determine the sequence for definitive management
Consult appropriate specialists, then initiate definitive local therapy.
The MRI findings directly guide the multidisciplinary decision between surgical decompression and radiation therapy.

Anahtar Kavram

Malignant epidural spinal cord compression is an oncologic emergency requiring the immediate empirical administration of high-dose corticosteroids before obtaining confirmatory imaging.
Soru 2172Soru →

During a routine primary care visit, the parents of a 5-year-old girl inquire about updating her vaccination status. The patient has a history of acute lymphoblastic leukemia, which was diagnosed six months ago, and she is actively receiving maintenance chemotherapy. Today, she appears well, and her temperature is 36.8°C (98.2°F). Her vaccination records indicate that she is due for her standard 4-to-6-year booster series, consisting of the diphtheria, tetanus, and acellular pertussis (DTaP); inactivated poliovirus (IPV); measles, mumps, and rubella (MMR); and varicella vaccines. What is the most appropriate approach to this patient's immunizations at this time?

Cevabı ve açıklamayı göster

Cevap: Administer the DTaP and IPV vaccines, but withhold the MMR and varicella vaccines

Cevap

Administer the DTaP and IPV vaccines, but withhold the MMR and varicella vaccines.
The correct approach is to administer the inactivated vaccines (DTaP and IPV) while withholding the live-attenuated vaccines (MMR and varicella). Children receiving active chemotherapy are profoundly immunocompromised. In such patients, live-attenuated vaccines pose a severe risk of causing life-threatening, disseminated vaccine-strain infections and are therefore absolutely contraindicated. In contrast, inactivated, subunit, or toxoid vaccines cannot replicate and are safe to administer. Although the immune response to inactivated vaccines may be blunted during chemotherapy, they should still be given on schedule to provide whatever degree of immunity is possible.

Adım Adım Çözüm

1
Identify the patient's immune status based on her medical history.
The patient is severely immunocompromised due to active maintenance chemotherapy for acute lymphoblastic leukemia.
Immune status directly determines which classes of vaccines are safe to administer.
2
Categorize the requested vaccines into live-attenuated versus inactivated types.
DTaP and IPV are inactivated vaccines. MMR and varicella are live-attenuated vaccines.
Different vaccine types have distinct safety profiles in immunocompromised hosts.
3
Apply standard immunization guidelines for immunocompromised pediatric patients.
Live-attenuated vaccines must be withheld to prevent vaccine-strain infection, while inactivated vaccines should be administered as scheduled.
This strategy maximizes protection against preventable diseases while avoiding the life-threatening risks associated with live vaccines.

Anahtar Kavram

In severely immunocompromised children, such as those on active chemotherapy, live-attenuated vaccines are absolutely contraindicated, while inactivated vaccines should be given as scheduled.
Soru 2173Soru →

A couple brings their 15-month-old daughter to the primary care clinic for a scheduled well-child visit. They are anxious because their friends' children of the same age are already walking independently, whereas their daughter only walks while holding onto furniture. The girl was born full-term and her medical history is unremarkable. On observation in the clinic, she easily pulls herself to a standing position and cruises smoothly along the examination table. When sitting, she uses a mature pincer grasp to pick up a small piece of cereal and successfully places a block into a cup. She babbles with varied inflection, uses the words "mama," "dada," and "ball" correctly, and follows a simple one-step command without needing an accompanying gesture. She maintains good eye contact and frequently points to objects she desires. Physical examination reveals normal muscle bulk and tone, and deep tendon reflexes are 2+ and symmetric in all extremities. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Provide reassurance and schedule the next routine well-child visit

Cevap

Provide reassurance and schedule the next routine well-child visit
The correct action is to provide reassurance and schedule routine follow-up. This patient is exhibiting normal developmental progression. While most children take their first independent steps between 12 and 15 months of age, it is considered entirely within the normal range to achieve this milestone up to 18 months. This patient demonstrates age-appropriate gross motor skills by pulling to stand and cruising smoothly. Furthermore, she is appropriately meeting fine motor (mature pincer grasp, placing a block in a cup), language (using 3 specific words, following a 1-step command without a gesture), and social (pointing to desired objects) milestones. Given her normal neurological examination and steady acquisition of skills, there is no evidence of a pathological process. Routine observation is the standard of care.

Adım Adım Çözüm

1
Analyze the patient's current gross motor milestone achievements against normal developmental timelines.
The patient pulls to stand and cruises, which are normal gross motor skills for a 15-month-old. Independent walking is not considered strictly delayed until 18 months of age.
Establishing whether a true developmental delay exists is the first step in deciding if clinical intervention is necessary.
2
Evaluate the patient's other developmental domains and physical examination findings.
Fine motor (mature pincer grasp), language (3 words, follows 1-step command without gesture), and social (points to objects) milestones are on track. The neurologic exam is normal.
A global developmental delay or focal neurologic deficits would require a comprehensive diagnostic workup, but an isolated perceived delay in walking with a normal exam is reassuring.
3
Determine the most appropriate management plan.
Reassurance and routine follow-up are indicated.
Since the child has not crossed the 18-month threshold for independent walking and has no other clinical red flags, medical investigations or subspecialty referrals are unwarranted.

Anahtar Kavram

Normal pediatric motor milestones indicate that most children walk independently by 12-15 months, but the normal range extends up to 18 months of age.
Tahmini Süre:1m 0s
Soru 2174Soru →

A 24-year-old woman, gravida 2 para 1, at 18 weeks gestation, presents to the clinic with a diffuse maculopapular rash that includes her palms and soles. She also reports generalized malaise and a low-grade fever over the past week. Her medical history is notable for a severe anaphylactic reaction (hypotension, wheezing, and angioedema) to amoxicillin prescribed for a respiratory infection two years ago. Laboratory evaluation reveals a rapid plasma reagin (RPR) titer of 1:64 and a reactive fluorescent treponemal antibody absorption (FTA-ABS) test. Arrange the following management steps in the most appropriate chronological order for this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is to first admit the patient to a monitored setting, perform a penicillin desensitization protocol, administer IM benzathine penicillin G, monitor for the Jarisch-Herxheimer reaction (including fetal monitoring), and finally follow up with repeat serologic testing later in the pregnancy.
This sequence correctly reflects the rigid, guideline-directed management of pregnant women with syphilis and a severe penicillin allergy. Because penicillin is the only universally effective drug for preventing congenital syphilis, the allergy must be temporarily bypassed via desensitization in a closely monitored setting. Following administration, the high risk of a Jarisch-Herxheimer reaction necessitates acute obstetrical monitoring. Finally, long-term serologic follow-up confirms resolution.

Adım Adım Çözüm

1
Recognize the absolute indication for penicillin in a pregnant patient with syphilis.
Determine that alternative regimens cannot be used.
Penicillin is the only proven therapy to cross the placenta reliably and prevent/treat congenital syphilis. Doxycycline is teratogenic, and macrolides have high resistance rates and poor placental transfer.
2
Address the patient's severe penicillin allergy history.
Plan for ICU admission and oral penicillin desensitization.
A history of anaphylaxis precludes a direct challenge. The patient must be admitted to a highly monitored setting to undergo step-wise desensitization, inducing temporary tolerance to the antibiotic.
3
Deliver the definitive antimicrobial therapy.
Administer intramuscular benzathine penicillin G.
Once desensitization is achieved, the therapeutic dose must be given immediately before the temporary tolerance wanes.
4
Anticipate and manage acute post-treatment complications.
Observe for the Jarisch-Herxheimer reaction and initiate continuous fetal monitoring.
Rapid lysis of spirochetes releases lipoproteins that trigger a systemic inflammatory cascade within 24 hours, posing a unique risk of fetal distress and preterm labor in pregnant patients.
5
Confirm long-term treatment success.
Schedule repeat quantitative RPR titers.
Serologic follow-up in the third trimester (28-32 weeks) and at delivery ensures the maternal titers have declined fourfold, indicating successful treatment of both mother and fetus.

Anahtar Kavram

Management of syphilis during pregnancy in patients with severe penicillin allergy requires ICU admission for desensitization followed by penicillin administration, as alternative antibiotics are contraindicated or ineffective for the fetus.
Soru 2175Soru →

A 45-year-old female patient presents to a primary care office complaining of unexpected weight gain, weakness in her thighs, and frequent bruising over the past six months. On examination, she has a plethoric face, prominent supraclavicular fat pads, and violaceous striae across her abdomen. Vital signs show a blood pressure of 155/95 mm Hg. Arrange the following diagnostic steps in the most appropriate chronological order to properly evaluate this presentation.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct diagnostic sequence is to first exclude exogenous glucocorticoid use, then confirm pathological hypercortisolism with a screening test (like 24-hour urine free cortisol), subsequently measure the serum ACTH level to determine dependency, and finally obtain targeted imaging such as a pituitary MRI.
The diagnostic algorithm for Cushing syndrome follows a strict sequence to avoid false positives and incidental findings. The very first step is to rule out exogenous glucocorticoid use. Once iatrogenic causes are excluded, pathological hypercortisolism must be biochemically confirmed using a primary screening test (24-hour urine free cortisol, late-night salivary cortisol, or a low-dose dexamethasone suppression test). Only after hypercortisolism is proven should an ACTH level be drawn to classify the source as ACTH-dependent or ACTH-independent. Finally, structural imaging (such as a pituitary MRI) is obtained solely to localize the tumor based on the biochemical pathway established.

Adım Adım Çözüm

1
Exclude iatrogenic etiology
Rule out exogenous glucocorticoid use
Iatrogenic Cushing syndrome is the most common cause and requires medication adjustment rather than an endogenous endocrine workup.
2
Confirm biochemical hypercortisolism
Perform primary screening tests (e.g., 24-hour urine free cortisol)
A pathological excess of cortisol must be definitively established before attempting to localize a potential tumor source.
3
Determine dependence on ACTH
Check serum ACTH level
This differentiates adrenal sources (suppressed ACTH) from pituitary or ectopic sources (normal to elevated ACTH).
4
Localize the specific lesion anatomically
Order dedicated imaging (e.g., pituitary MRI)
Imaging is only performed to localize the tumor once the biochemical profile dictates the appropriate anatomical location.

Anahtar Kavram

The sequential diagnostic algorithm for Cushing syndrome.
Tahmini Süre:1m 0s
Soru 2176Soru →

During a routine clinic visit, a 62-year-old male veteran complains of severe, widespread itching that reliably occurs within minutes of stepping out of a warm shower. He also reports recent onset of headaches and a sensation of fullness in his head. Physical examination reveals a ruddy facial complexion and a palpable spleen edge extending 33 cm below the left costal margin. Laboratory studies reveal:

TestValue
Hemoglobin19.219.2 g/dL
Leukocytes14,20014,200/mm³
Platelets550,000550,000/mm³

Which of the following is the most appropriate next diagnostic step for this patient?

Cevabı ve açıklamayı göster

Cevap: Peripheral blood mutation analysis for JAK2

Cevap

Peripheral blood mutation analysis for JAK2 is the most appropriate next diagnostic step to confirm suspected Polycythemia Vera.
The patient's presentation of aquagenic pruritus (itching specifically after hot showers), facial plethora, splenomegaly, and panmyelosis (elevated erythrocytes, leukocytes, and platelets) is the classic triad of findings for Polycythemia Vera (PV). PV is a clonal myeloproliferative disorder driven primarily by a somatic mutation in the Janus kinase 2 (JAK2) gene, resulting in constitutive tyrosine kinase activity and EPO-independent proliferation of myeloid cells. The most appropriate initial diagnostic step is peripheral blood testing for the JAK2 V617F mutation (present in >95%>95\% of cases), typically ordered alongside a serum erythropoietin level (which would be low).

Adım Adım Çözüm

1
Identify the clinical syndrome from the patient's presentation and lab findings.
The patient exhibits aquagenic pruritus, facial plethora, splenomegaly, and panmyelosis (simultaneous elevation of red blood cells, white blood cells, and platelets).
Recognizing this combination of findings correctly points toward a myeloproliferative neoplasm rather than a reactive or secondary process.
2
Determine the appropriate initial diagnostic sequence for the suspected condition.
The most accurate, non-invasive initial test for Polycythemia Vera is peripheral blood testing for a JAK2 mutation.
The JAK2 V617F mutation is present in over 95% of patients with Polycythemia Vera. Testing for this mutation in the peripheral blood avoids immediate invasive procedures like bone marrow biopsy.

Anahtar Kavram

Polycythemia vera presents with hyperviscosity symptoms, aquagenic pruritus, splenomegaly, and panmyelosis, and is initially diagnosed via non-invasive peripheral blood JAK2 mutation analysis.
Soru 2177Soru →

A 22-year-old man is admitted to the hospital for initiation of induction chemotherapy for recently diagnosed Burkitt lymphoma. His medical history is significant for an episode of acute jaundice, fatigue, and dark urine two years ago after taking primaquine for malaria prophylaxis; the episode spontaneously resolved upon discontinuation of the medication. The patient currently feels well and reports no symptoms. His temperature is 37.1°C (98.8°F), blood pressure is 120/78 mm Hg, and pulse is 82/min. Physical examination reveals prominent cervical and axillary lymphadenopathy but is otherwise unremarkable.

Laboratory studies show:
LabValueReference Range
Hemoglobin13.8 g/dL13.5-17.5 g/dL
Leukocyte count18,500/mm³4,500-11,000/mm³
Platelet count210,000/mm³150,000-400,000/mm³
Blood urea nitrogen18 mg/dL8-20 mg/dL
Serum creatinine1.2 mg/dL0.7-1.3 mg/dL
Potassium4.6 mEq/L3.5-5.0 mEq/L
Calcium8.8 mg/dL8.4-10.2 mg/dL
Phosphorus4.9 mg/dL2.5-4.5 mg/dL
Uric acid14.2 mg/dL4.0-8.0 mg/dL
Lactate dehydrogenase1,850 U/L100-250 U/L

The patient is started on aggressive intravenous normal saline hydration. Which of the following is the most appropriate next step in the management of this patient's hyperuricemia?

Cevabı ve açıklamayı göster

Cevap: Administration of intravenous allopurinol

Cevap

The most appropriate next step is the administration of intravenous allopurinol because rasburicase is contraindicated in patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency.
The correct answer is the administration of intravenous allopurinol. This patient has newly diagnosed Burkitt lymphoma (a highly proliferative tumor) and an elevated uric acid level of 14.2 mg/dL, placing him at high risk for Tumor Lysis Syndrome (TLS). While rasburicase (a recombinant urate oxidase) is the preferred treatment for high-risk TLS with established hyperuricemia because it rapidly degrades existing uric acid into highly soluble allantoin, it is strictly contraindicated in this patient. His history of acute hemolysis following primaquine administration is pathognomonic for Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency. Rasburicase catalyzes the oxidation of uric acid, producing hydrogen peroxide (H2O2H_2O_2) as a byproduct. In G6PD deficiency, the inability to generate sufficient NADPH prevents the reduction of glutathione, neutralizing the oxidative stress from H2O2H_2O_2. This leads to severe, potentially fatal hemolysis and methemoglobinemia. Therefore, allopurinol, a xanthine oxidase inhibitor that prevents new uric acid formation without generating oxidative stress, is the most appropriate alternative.

Adım Adım Çözüm

1
Assess the patient's risk for Tumor Lysis Syndrome (TLS).
High risk due to newly diagnosed Burkitt lymphoma and a significantly elevated uric acid level of 14.2 mg/dL.
Identifying the severity of TLS risk determines the aggressiveness of the urate-lowering therapy required.
2
Determine the standard of care for high-risk TLS with established hyperuricemia.
Rasburicase (recombinant urate oxidase) is typically the first-line pharmacologic intervention.
Rasburicase rapidly degrades existing uric acid, whereas allopurinol only prevents the formation of new uric acid.
3
Evaluate the patient's medical history for contraindications.
The history of primaquine-induced hemolysis indicates Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency.
Primaquine is a classic oxidative trigger that causes acute hemolytic anemia in G6PD deficient individuals.
4
Select the safest alternative urate-lowering therapy.
Intravenous allopurinol must be administered instead of rasburicase.
Rasburicase generates hydrogen peroxide (H2O2H_2O_2) and is strictly contraindicated in G6PD deficiency; allopurinol is the appropriate alternative.

Anahtar Kavram

Rasburicase is contraindicated in patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency due to the risk of severe hemolysis and methemoglobinemia from hydrogen peroxide accumulation.
Soru 2178Soru →

Match each specific autoantibody profile with its most strongly associated rheumatologic condition.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Anti-double-stranded DNA (anti-dsDNA)
Anti-centromere antibody
Anti-Jo-1 antibody
Anti-cyclic citrullinated peptide (anti-CCP)

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct pairings are: Anti-dsDNA matches with Systemic lupus erythematosus (SLE); Anti-centromere matches with Limited cutaneous systemic sclerosis; Anti-Jo-1 matches with Polymyositis / Dermatomyositis; Anti-CCP matches with Rheumatoid arthritis.
Each autoantibody listed has a distinct, classic disease association commonly tested on the USMLE. Anti-dsDNA is specific for SLE, anti-centromere for limited systemic sclerosis, anti-Jo-1 for inflammatory myopathies, and anti-CCP for rheumatoid arthritis. Recognizing these fundamental associations is essential for diagnosing systemic autoimmune disorders.

Adım Adım Çözüm

1
Identify the target disease for anti-dsDNA.
Systemic lupus erythematosus (SLE).
Anti-dsDNA is a classic, highly specific diagnostic marker for SLE.
2
Identify the target disease for anti-centromere antibodies.
Limited cutaneous systemic sclerosis.
This antibody is uniquely linked to the limited cutaneous subtype of scleroderma.
3
Identify the target disease for anti-Jo-1 antibodies.
Polymyositis / Dermatomyositis.
Anti-Jo-1 targets histidyl-tRNA synthetase and is classically seen in these inflammatory myopathies.
4
Identify the target disease for anti-CCP.
Rheumatoid arthritis.
Anti-CCP is the most specific serologic test available for diagnosing rheumatoid arthritis.

Anahtar Kavram

Serologic autoantibody profiles in specific rheumatologic diseases
Soru 2179Soru →

A 34-year-old woman is brought to the emergency department by her husband due to progressive confusion and severe fatigue over the past 48 hours. She also complains of a new-onset rash on her lower extremities. She has no significant past medical history and takes no medications. Temperature is 38.1°C (100.6°F), blood pressure is 142/85 mm Hg, pulse is 110/min, and respiratory rate is 18/min. Physical examination reveals mild scleral icterus and pale conjunctivae. There are numerous pinpoint, non-blanching red macules over both lower extremities. Neurological examination is notable for mild disorientation to time and place, but no focal motor or sensory deficits are present.

Laboratory results are as follows:

Laboratory TestResultReference Range
Hemoglobin7.6 g/dL12.0-15.5 g/dL
Platelets18,000/mm³150,000-400,000/mm³
Leukocytes8,400/mm³4,500-11,000/mm³
Creatinine1.6 mg/dL0.6-1.1 mg/dL
Total bilirubin3.8 mg/dL0.1-1.2 mg/dL
Indirect bilirubin3.2 mg/dL0.1-0.8 mg/dL
Lactate dehydrogenase (LDH)1,150 U/L100-250 U/L
Prothrombin time (PT)11.5 sec11-15 sec
Activated partial thromboplastin time (aPTT)28 sec25-40 sec
Fibrinogen350 mg/dL150-400 mg/dL

A peripheral blood smear demonstrates numerous fragmented red blood cells.

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Plasma exchange

Cevap

Plasma exchange is the most appropriate next step in management.
The correct answer addresses the underlying pathophysiology of Thrombotic Thrombocytopenic Purpura (TTP). The patient exhibits the classic pentad of TTP: microangiopathic hemolytic anemia (schistocytes, elevated LDH, indirect hyperbilirubinemia, anemia), thrombocytopenia, fever, acute kidney injury, and neurologic abnormalities (confusion). A presumptive diagnosis requires only the presence of MAHA and thrombocytopenia without another clear cause. TTP is typically caused by an acquired autoantibody against ADAMTS13, a metalloprotease that cleaves von Willebrand factor (vWF). Without it, ultra-large vWF multimers accumulate, causing systemic platelet trapping and microvascular thrombosis. Immediate plasma exchange (plasmapheresis) is the treatment of choice; it removes the autoantibodies and replenishes the deficient ADAMTS13 enzyme.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation.
A young woman presents with acute confusion, severe fatigue, fever, and a petechial rash.
Establishing the initial constellation of symptoms helps frame the differential diagnosis for an acutely ill patient with bleeding signs.
2
Evaluate the laboratory findings and peripheral smear.
Labs show severe thrombocytopenia, hemolytic anemia (elevated indirect bilirubin and LDH), acute kidney injury, and schistocytes. Coagulation studies (PT, aPTT, fibrinogen) are normal.
Differentiating between causes of microangiopathic hemolytic anemia (MAHA) and thrombocytopenia is crucial for determining management.
3
Synthesize the findings to establish a diagnosis.
The combination of MAHA, thrombocytopenia, fever, renal dysfunction, and neurologic changes (classic pentad), along with normal coagulation, confirms Thrombotic Thrombocytopenic Purpura (TTP).
TTP is caused by a severe deficiency in the ADAMTS13 enzyme, leading to unchecked platelet aggregation on ultra-large von Willebrand factor multimers.
4
Determine the most appropriate intervention.
Immediate plasma exchange must be initiated.
Plasma exchange removes the offending autoantibody and provides functional ADAMTS13 enzyme, significantly reducing the high mortality rate associated with untreated TTP.

Anahtar Kavram

Diagnosis and emergent management of thrombotic thrombocytopenic purpura (TTP) using plasma exchange.
Soru 2180Soru →

A physician is evaluating the antimicrobial regimen of a patient on the medical floor. The patient, a 58-year-old male, was admitted three days prior for management of severe shortness of breath and a productive cough. At the time of admission, imaging confirmed a left lower lobe consolidation, prompting the initiation of empiric intravenous ceftriaxone and azithromycin. Currently, the patient is clinically stable, breathing comfortably on ambient air, and tolerating his regular diet. He has not had a fever for over 24 hours. Laboratory data today reveals that the initial blood cultures are sterile. However, the admission sputum culture has finalized, demonstrating heavy growth of *Streptococcus pneumoniae*. Susceptibility profiling indicates the isolate is sensitive to penicillin, amoxicillin, levofloxacin, ceftriaxone, and vancomycin. Which of the following is the most appropriate next step in the pharmacologic management of this patient?

Cevabı ve açıklamayı göster

Cevap: Transition to oral amoxicillin

Cevap

Transitioning to oral amoxicillin is the most appropriate step, as it provides optimal, narrow-spectrum therapy for this specific pathogen.
This patient was admitted with community-acquired pneumonia (CAP) and appropriately started on an empiric broad-spectrum regimen covering both typical and atypical pathogens. He has now achieved clinical stability—evidenced by being afebrile, oxygenating well on ambient air, and tolerating an oral diet—making him eligible for step-down therapy from intravenous to oral antibiotics. Furthermore, his sputum culture definitively identified *Streptococcus pneumoniae* as the sole causative pathogen, and susceptibility testing confirms it is sensitive to penicillin. The core principles of antimicrobial stewardship mandate de-escalating therapy to the narrowest effective agent once a specific pathogen is isolated. For a penicillin-susceptible *S. pneumoniae* isolate, high-dose oral amoxicillin is the preferred narrow-spectrum step-down therapy. Continuing atypical coverage (azithromycin) is no longer necessary since a definitive typical pathogen has been identified.

Adım Adım Çözüm

1
Evaluate the patient's clinical trajectory and readiness for step-down therapy.
The patient is afebrile, hemodynamically stable, off supplemental oxygen, and tolerating oral intake.
Clinical stability indicates the patient is ready to transition from intravenous to oral antibiotic therapy.
2
Analyze the finalized microbiological data to determine the targeted treatment.
The sputum culture definitively isolated Streptococcus pneumoniae that is fully susceptible to penicillin and amoxicillin.
Identifying the specific pathogen allows for de-escalation from empiric broad-spectrum coverage.
3
Apply principles of antimicrobial stewardship to select the ideal definitive oral agent.
Oral amoxicillin is selected as the narrowest effective agent.
Narrow-spectrum therapy minimizes adverse effects, preserves normal flora, and reduces the risk of generating antimicrobial resistance.

Anahtar Kavram

Once a patient with community-acquired pneumonia demonstrates clinical stability and a specific susceptible pathogen is identified, empiric broad-spectrum therapy should be de-escalated to a targeted, narrow-spectrum oral agent.
Tahmini Süre:1m 0s
ÖncekiSayfa 109 / 414Sonraki
Tüm alıştırma soruları — USMLE Step 2 CK | Examkin